ent-16β,17-Dihydroxykauran-19-oic acid

• UNSPSC Description:

  ent-16β,17-Dihydroxykauran-19-oic acid is an anti-inflammatory agent, which can be isolated from Siegesbeckia pubescens herb. ent-16β,17-Dihydroxykauran-19-oic acid inhibits lipopolysaccharide-induced nitric oxide production in BV2 microglia[1].

• Target Antigen:

  Others

• Type:

  Natural Products

• Related Pathways:

  Others

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/ent-16β-17-dihydroxykauran-19-oic-acid.html

• Purity:

  98.0

• Solubility:

  10 mM in DMSO

• Smiles:

  C[C@]12[C@@]3([H])[C@]4(CC[C@]1([H])[C@@](C)(CCC2)C(O)=O)C[C@@](O)([C@@](CC3)([H])C4)CO

• Molecular Weight:

  336.47

• References & Citations:

  [1]Lee M, et al. ent-kaurane and ent-pimarane diterpenes from Siegesbeckia pubescens inhibit lipopolysaccharide-induced nitric oxide production in BV2 microglia. Biol Pharm Bull. 2014;37(1):152-7.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C (Powder, protect from light)

• Clinical Information:

  No Development Reported

• CAS Number:

  3301-61-9